Anders Sönnerborg to Piperazines
This is a "connection" page, showing publications Anders Sönnerborg has written about Piperazines.
Connection Strength
0.176
-
Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes. AIDS. 2018 02 20; 32(4):469-476.
Score: 0.141
-
Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations. Int J Antimicrob Agents. 2018 May; 51(5):733-738.
Score: 0.035